Immix Biopharma Inc（IMMX）价格预测

$8.150

-0.196 (-2.40%)收盘时

价格预测

1-Day Price Prediction

+0.60%

1-Week Prediction

+1.14%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

IMMX 相似图表分析预测

Alphio's IMMX stock price prediction model matches the current Immix Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.20 (+0.60%). The 1-week path is $8.24 (+1.14%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Immix Biopharma Inc 股票吗？

Immix Biopharma Inc is a good buy right now due to its promising clinical trial results for NXC-201, which demonstrated an 89% complete response rate in patients, and a strong analyst price target of $30, indicating over 190% upside potential from the current price of $8.15. The main risk is the company's negative earnings per share (EPS) of -0.18 expected in the upcoming earnings report, reflecting ongoing financial challenges.

IMMX 股价于 Friday 收于 $8.15，此前下跌 -2.40%

Immix Biopharma Inc (IMMX) last closed at $8.15, losing -2.40%. These facts feed the 1-day and 1-week IMMX price prediction above.

预测驱动因素

Immix Biopharma Inc（IMMX）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 IMMX 最接近的股票，按相似度排序。

AMZN

91.76%

+11.91%

CUZ

90.59%

+6.36%

HIW

90.26%

+11.53%

KOD

90.04%

-32.28%

CIG

89.87%

+7.32%

IMMX 季节性分析

Historically the probability of a positive October return for IMMX is 58.73%. July offers the highest probability of a positive month at 65.15%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…